相关实验视频

Updated: Jul 24, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

皮克林乳液和BLS蛋白纳米颗粒的联合应用增强了疫苗的疗效

Jianghua Yang¹, Xiang Liu¹, Haoyan Yang¹

¹Key Laboratory of Livestock Infectious Diseases in Northeast China, Ministry of Education, College of Animal Science and Veterinary Medicine, Shenyang Agricultural University. Liaoning Province, Shenyang 110866, PR China.

International journal of biological macromolecules

|November 15, 2024

概括

使用Brucella lumazine synthase (BLS) 和酸盐稳定皮克林乳液 (CHSPE) 辅助剂的新型纳米支架疫苗显著增强了细胞免疫反应和保护. 这种组合为开发有效的重组蛋白子单元疫苗提供了有前途的战略.

科学领域:

疫苗学疫苗学疫苗学
纳米技术纳米技术
免疫学免疫学免疫学

背景情况:

再组合蛋白质疫苗经常难以诱导持久的细胞免疫力.
现有的辅助剂在引起强大和持久的免疫反应方面存在局限性.
纳米粒子平台和免疫增强剂显示出提高疫苗疗效的潜力.

研究的目的:

使用Brucella lumazine synthase (BLS) 设计一个最佳的蛋白质纳米支架.
评估基托桑化物稳定皮克林乳液 (CHSPE) 作为BLS基疫苗的辅助剂.
评估CHSPE增强细胞和幽默免疫反应的能力.

主要方法:

工程BLS纳米支架用于抗原显示,细胞吸收和树突细胞 (DC) 成熟.
用CHSPE辅助剂配制的BLS疫苗,并与商业辅助剂ISA 206进行比较.
评估了注射部位和淋巴结的DC招募和激活.
测量了抗原特异性抗体水平,T细胞记忆群 (TCM,TEM) 和Th1细胞因子分泌.
与活体减弱疫苗和ISA 206相比,评估了疫苗对挑战的保护.

主要成果:

CHSPE增强了DC的招募和激活,改善了抗原吸收和DC的成熟.
用CHSPE配制的疫苗诱导的抗体水平与ISA 206相似.
CHSPE增加了中央记忆T细胞 (TCM) 和效应记忆T细胞 (TEM) 的比例.
CHSPE促进了Th1型细胞因子的分泌,这表明细胞免疫反应更强.
配备了CHSPE的疫苗提供了与活体减弱疫苗相当的保护,并且优于ISA 206.

结论:

BLS纳米支架有效地促进了抗原呈现和DC成熟.
CHSPE作为一种强大的辅助剂,增强细胞和幽默免疫力.
BLS纳米和CHSPE的组合代表了开发先进的重组蛋白子单元疫苗的可行战略.

关键词:

基托桑是一种酸盐.皮克林乳液是一种皮克林乳液.蛋白质纳米颗粒蛋白质纳米颗粒疫苗疫苗疫苗疫苗

更多相关视频

Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization

Cellular Affinity of Particle-Stabilized Emulsion to Boost Antigen Internalization

Published on: September 2, 2022

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

相关概念视频

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.